BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4186 related articles for article (PubMed ID: 30261893)

  • 21. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
    Yang K; Lu XF; Luo PC; Zhang J
    Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
    [No Abstract]   [Full Text] [Related]  

  • 22. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors.
    Chen K; Bai L; Ji L; Wu L; Li G
    Medicine (Baltimore); 2021 Jun; 100(24):e26271. PubMed ID: 34128858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
    Hu J; Xu L; Shou T; Chen Q
    Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatic analysis of differentially expressed profiles of lncRNAs and miRNAs with their related ceRNA network in endometrial cancer.
    Li F; Zhou C; Li S; Wang J; Li M; Mu H
    Medicine (Baltimore); 2023 Jan; 102(3):e32573. PubMed ID: 36701720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
    Luo R; Song J; Zhang W; Ran L
    Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
    Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
    Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
    Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
    Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
    Zhao G; Fu Y; Su Z; Wu R
    Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.
    Gao X; Zhang W; Jia Y; Xu H; Zhu Y; Pei X
    Sci Rep; 2022 Sep; 12(1):16247. PubMed ID: 36171401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.
    Naorem LD; Prakash VS; Muthaiyan M; Venkatesan A
    Int J Biol Macromol; 2020 Feb; 145():429-436. PubMed ID: 31883894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
    Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
    World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 210.